These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21783371)

  • 1. Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides.
    Bachan S; Fantini J; Joshi A; Garg H; Mootoo DR
    Bioorg Med Chem; 2011 Aug; 19(16):4803-11. PubMed ID: 21783371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry.
    Fantini J; Hammache D; Delézay O; Yahi N; André-Barrès C; Rico-Lattes I; Lattes A
    J Biol Chem; 1997 Mar; 272(11):7245-52. PubMed ID: 9054420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.
    Yahi N; Sabatier JM; Baghdiguian S; Gonzalez-Scarano F; Fantini J
    J Virol; 1995 Jan; 69(1):320-5. PubMed ID: 7983725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V3 loop-derived peptide SPC3 inhibits infection of CD4- and galactosylceramide- cells by LAV-2/B.
    Moulard M; Mabrouk K; Martin I; Van Rietschoten J; Rochat H; Sabatier JM
    J Pept Res; 1999 Jun; 53(6):647-55. PubMed ID: 10408339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.
    Cook DG; Fantini J; Spitalnik SL; Gonzalez-Scarano F
    Virology; 1994 Jun; 201(2):206-14. PubMed ID: 8184533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells.
    Yahi N; Sabatier JM; Nickel P; Mabrouk K; Gonzalez-Scarano F; Fantini J
    J Biol Chem; 1994 Sep; 269(39):24349-53. PubMed ID: 7929093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.
    Nehete PN; Vela EM; Hossain MM; Sarkar AK; Yahi N; Fantini J; Sastry KJ
    Antiviral Res; 2002 Dec; 56(3):233-51. PubMed ID: 12406507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry.
    Garg H; Francella N; Tony KA; Augustine LA; Barchi JJ; Fantini J; Puri A; Mootoo DR; Blumenthal R
    Antiviral Res; 2008 Oct; 80(1):54-61. PubMed ID: 18538869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
    Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
    PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide.
    Weber KT; Hammache D; Fantini J; Ganem B
    Bioorg Med Chem Lett; 2000 May; 10(10):1011-4. PubMed ID: 10843204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric synthesis of water-soluble analogues of galactosylceramide, an HIV-1 receptor: new tools to study virus-glycolipid interactions.
    Villard R; Hammache D; Delapierre G; Fotiadu F; Buono G; Fantini J
    Chembiochem; 2002 Jun; 3(6):517-25. PubMed ID: 12325007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density dependent interaction of polymeric analogs of beta-galactosyl ceramide with GP120 of human immunodeficiency virus 1.
    Fujita E; Nishimura SI
    Carbohydr Lett; 2000; 4(1):53-60. PubMed ID: 11469338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide.
    Long D; Berson JF; Cook DG; Doms RW
    J Virol; 1994 Sep; 68(9):5890-8. PubMed ID: 8057468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the potential regions of Epap-1 that interacts with V3 loop of HIV-1 gp120.
    Bhaskar C; Reddy PS; Chandra KS; Sabde S; Mitra D; Kondapi AK
    Biochim Biophys Acta; 2013 Apr; 1834(4):780-90. PubMed ID: 23360764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.
    Augustin LA; Fantini J; Mootoo DR
    Bioorg Med Chem; 2006 Feb; 14(4):1182-8. PubMed ID: 16216516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthetic peptide derived from the NH2-terminal extracellular region of an orphan G protein-coupled receptor, GPR1, preferentially inhibits infection of X4 HIV-1.
    Jinno-Oue A; Shimizu N; Soda Y; Tanaka A; Ohtsuki T; Kurosaki D; Suzuki Y; Hoshino H
    J Biol Chem; 2005 Sep; 280(35):30924-34. PubMed ID: 15919664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture.
    Chertov O; Zhang N; Chen X; Oppenheim JJ; Lubkowski J; McGrath C; Sowder RC; Crise BJ; Malyguine A; Kutzler MA; Steele AD; Henderson EE; Rogers TJ
    PLoS One; 2011 Jan; 6(1):e14474. PubMed ID: 21264298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.